2008 Summer Meeting - Leeds - The Pathological Society of Great ...

14.45–15.00 [O4] Predicting outcomes in sporadic versus hereditary breast cancer: a limitedimmunohistochemical panel does not identify BRCA1 and BRCA2 carriers{P} DL Holliday, C Chelala, P Goinath, DM Eccles, JL Jones15.00–15.15 [O5] An altered myoepithelial cell phenotype in DCIS influences tumour-associatedangiogenesis{P} SJL Payne, M Allen, I Hart, JL Jones15.15–15.30 [O6] Genomic and immunophenotypical characterisation of pure micropapillarycarcinomas of the breast{P} C Marchio, M Iravani, R Natrajan, MB Lambros, K Savage, S Di Palma,FC Schmitt, G Bussolati, IO Ellis, A Ashworth, A Sapino, JS Reis-Filho15.30–16.10 TEA [SPORTS HALL 1]Detailed Programme – Tuesday 1 July 2008Presenter = {P} · Abstract numbers are shown in bold and square brackets eg [S123]16.10–16.25 [O7] Neural networks identify gene profiles that predict clinical outcome with highaccuracy in breast cancer: CA IX is identified as the principal prognostic indicatorLJ Lancashire, {P} DG Powe, E Rakha, AR Green, R Mukta, EC Paish, RC Rees,IO Ellis, GR Ball16.25–16.40 [O8] Clear cells of the nipple epidermis: a reserve of motile mammary precursor cells?{P} J Going, M Currie16.40–16.55 [O9] Development and characterisation of a new breast cancer cell line of basalphenotype{P} V Speirs, CA Green, RH Partanen, AM Shaaban, AM Hanby14.00–17.00 Conference Auditorium 2ORAL COMMUNICATIONS: GastrointestinalChair: Dr MJ Arends, University of CambridgeDr N Scott, St James’s Institute of Oncology, Leeds14.00–14.15 [O10] Methylation pattern of high risk flat adenomas in CRC{P} QJM Voorham, B Carvalho, AJ Spiertz, NCT Van Grieken, S Derks,H Grabsch, B Rembacken, AP De Bruïne, M Van Engeland, GA Meijer14.15–14.30 [O11] Combining proteomics and genomics to identify biomarkers for colorectal cancer{P} M De Wit, CR Jimenez, B Carvalho, S Piersma, R Lamerichs, GA Meijer,RJA Fijneman14.30–14.45 [O12] Chromosomal aberrations and APC promoter methylation in sporadic and coeliacdisease related small intestinal adenocarcinomas{P} B Diosdado, TE Buffart, M Tijssen, BJ Bolijn, B Ylstra, B Carvalho,R Watkins, F Lewis, ID Nagtegaal, CJJ Mulder, K Maude, H Grabsch, P Quirke,P Howdle, GA Meijer14.45–15.00 [O13] K-Ras and B-Raf mutations in the MRC CR08 FOCUS Trial{P} S Richman, P Chambers, F Elliott, C Daly, M Braun, J Barrett, G Taylor,P Quirke, M Seymour, and MRC Focus Investigators15.00–15.15 [O14] Patient survival according to the quality of colonic cancer surgery: time for action?{P} NP West, EJA Morris, O Rotimi, A Cairns, PJ Finan, P Quirke12 Summer Meeting (194 th ) 1–4 July 2008 Scientific Programme